BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12489282)

  • 41. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What is the optimal interval of surveillance colonoscopy in patients with long-standing ulcerative colitis?
    Connell W
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S194-5. PubMed ID: 18816747
    [No Abstract]   [Full Text] [Related]  

  • 43. Colorectal cancer in inflammatory bowel disease: a shift in risk?
    Gallinger ZR; Weizman AV
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):847-56. PubMed ID: 24621115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease.
    Hsiao SW; Yen HH; Chen YY
    Gut Liver; 2022 Nov; 16(6):840-848. PubMed ID: 35670121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence.
    Bezzio C; Festa S; Saibeni S; Papi C
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):339-347. PubMed ID: 28165825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.
    Mouzas IA; Papavassiliou E; Koutroubakis I
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.
    Pulusu SSR; Lawrance IC
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):711-722. PubMed ID: 28475382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IBD-related carcinoma and lymphoma.
    Claessen MM; Siersema PD; Vleggaar FP
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of cancer in IBD - a balancing act.
    Mill J; Lawrance IC
    Minerva Gastroenterol Dietol; 2013 Sep; 59(3):261-72. PubMed ID: 23867946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemoprevention of colorectal cancer in inflammatory bowel disease.
    Subramanian V; Logan RF
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
    Wang YR; Cangemi JR; Loftus EV; Picco MF
    Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory bowel disease and cancer.
    Itzkowitz SH
    Gastroenterol Clin North Am; 1997 Mar; 26(1):129-39. PubMed ID: 9119437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must.
    Nett A; Velayos F; McQuaid K
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):379-92. PubMed ID: 24975529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.
    Boursi B; Arber N
    Curr Pharm Des; 2007; 13(22):2274-82. PubMed ID: 17692000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges in designing a randomized trial of surveillance colonoscopy in IBD.
    Bernstein CN
    Inflamm Bowel Dis; 1998 May; 4(2):132-41. PubMed ID: 9589298
    [No Abstract]   [Full Text] [Related]  

  • 58. Surveillance of patients with inflammatory bowel disease.
    Yu JX; East JE; Kaltenbach T
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
    Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
    Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.
    Herrinton LJ; Liu L; Levin TR; Allison JE; Lewis JD; Velayos F
    Gastroenterology; 2012 Aug; 143(2):382-9. PubMed ID: 22609382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.